A River of News

Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA

12 publications, in the order they reported. The story spread over 77 hours 11 minutes. Words in highlight are ones the first headline did not use. All top stories · On NewsMarkets

Share: Bluesky · X · Facebook · LinkedIn · Email

Publications over time

17:49 UTC23:00 UTC12 publications
Publications in order of reporting
#Time (UTC)After the firstPublicationHeadline
1firstSTAT (paywall)Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA by Scott Gottlieb, Mark B. McClellan
2+39 hours 11 minutesWashington Post (limited free articles)Trump’s FDA pick to face scrutiny on vaccines, abortion pill by Rachel Roubein
3+39 hours 14 minutesThe New York Times (limited free articles)Abortion Pills, Vaccines and Food Safety: F.D.A. Nominee Heidi Overton Faces Senate Confirmation Hearing by Christina Jewett, Pam Belluck
4+40 hours 11 minutesThe HillTrump FDA pick tests Collins on abortion by Nathaniel Weixel
5+46 hours 37 minutesThe GuardianTrump’s FDA nominee says MMR shot is ‘safe and effective’ at Senate hearing by Joseph Gedeon
6+48 hours 11 minutesScientific American (limited free articles)Trump’s FDA nominee Heidi Overton affirms MMR vaccine and mifepristone are safe at crucial Senate hearing
7+49 hours 48 minutesFox NewsTrump FDA pick repeatedly sidesteps Sanders' universal healthcare demands in heated clash
8+50 hours 13 minutesMother JonesTrump’s FDA Pick Refuses to Say IUDs Don’t Cause Abortions by Garnet Henderson, Susan Rinkunas
9+51 hours 42 minutesRoll CallFDA nominee evasive on abortion pill but firm on vaccine safety by Ariel Cohen
10+51 hours 53 minutesMedPage TodayFDA Nominee Voices Support for Vaccines at Senate Hearing Scrutinizing Trump's Moves
11+53 hours 7 minutesNPRPresident Trump's FDA commissioner nom, Dr. Heidi Overton, faces Senators' questions by Sydney Lupkin
12+77 hours 11 minutesArs TechnicaCan Trump ever be wrong? His pick to lead FDA refused to say. by Beth Mole